• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.采用液相色谱-串联质谱法测定血液透析患者血清中蛋白结合尿毒症毒素水平的相关性
Mass Spectrom (Tokyo). 2013;2(Spec Iss):S0017. doi: 10.5702/massspectrometry.S0017. Epub 2013 Apr 15.
2
Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.用液相色谱/串联质谱法测定血液透析患者的蛋白结合型尿毒症毒素及其对内皮细胞 ROS 产生的影响。
Anal Bioanal Chem. 2012 Jun;403(7):1841-50. doi: 10.1007/s00216-012-5929-3. Epub 2012 Mar 25.
3
Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.使用结合竞争剂去除血液透析中的蛋白结合型尿毒症毒素。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):394-402. doi: 10.2215/CJN.05240418. Epub 2019 Feb 12.
4
Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers.健康志愿者唾液中游离尿毒症毒素水平与血清中游离尿毒症毒素水平的相关性。
Toxins (Basel). 2023 Feb 13;15(2):150. doi: 10.3390/toxins15020150.
5
Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病中降低蛋白结合型尿毒症毒素的策略:系统评价和荟萃分析。
J Nephrol. 2021 Dec;34(6):1805-1817. doi: 10.1007/s40620-020-00955-2. Epub 2021 Jan 23.
6
p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis.接受长期透析的儿科患者体内的对甲酚硫酸盐和吲哚酚硫酸盐
Korean J Pediatr. 2013 Apr;56(4):159-64. doi: 10.3345/kjp.2013.56.4.159. Epub 2013 Apr 22.
7
Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?西那卡塞或烟酰胺治疗是否能改变慢性血液透析患者的尿毒症毒素或内毒素血症?
Drugs. 2019 Jun;79(8):855-862. doi: 10.1007/s40265-019-01118-9.
8
Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.慢性肾脏病(CKD)患者体内的蛋白结合型尿毒症毒素(PBUTs):产生途径、面临的挑战及肾脏 PBUTs 清除的最新进展。
NanoImpact. 2021 Jan;21:100299. doi: 10.1016/j.impact.2021.100299. Epub 2021 Jan 28.
9
Quantification of free and protein bound uremic toxins in human serum by LC-MS/MS: Comparison of rapid equilibrium dialysis and ultrafiltration.采用 LC-MS/MS 定量检测人血清中游离和蛋白结合型尿毒症毒素:快速平衡透析法与超滤法的比较。
Clin Chim Acta. 2020 Aug;507:228-235. doi: 10.1016/j.cca.2020.04.032. Epub 2020 May 3.
10
The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.等渗血液透析对尿毒症潴留溶质结合及清除的影响。
PLoS One. 2018 Feb 22;13(2):e0192770. doi: 10.1371/journal.pone.0192770. eCollection 2018.

引用本文的文献

1
Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease.终末期肾病患者的肠道微生物组和微生物组衍生代谢物。
Int J Mol Sci. 2023 Jul 14;24(14):11456. doi: 10.3390/ijms241411456.
2
Ameliorating effect of probiotics in a rat model of chronic kidney disease.益生菌对慢性肾脏病大鼠模型的改善作用。
PLoS One. 2023 Mar 30;18(3):e0281745. doi: 10.1371/journal.pone.0281745. eCollection 2023.
3
Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice.慢性肾脏病中肠道来源的尿毒症毒素:一种改进的血清吲哚硫酸酯在临床实践中的评估方法。
Int J Mol Sci. 2023 Mar 7;24(6):5142. doi: 10.3390/ijms24065142.
4
Impact of a 7-day homogeneous diet on interpersonal variation in human gut microbiomes and metabolomes.7 天同质饮食对人体肠道微生物组和代谢组中人际变异性的影响。
Cell Host Microbe. 2022 Jun 8;30(6):863-874.e4. doi: 10.1016/j.chom.2022.05.003. Epub 2022 May 27.
5
Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease.影响慢性肾脏病的芳烃受体机制
Front Pharmacol. 2022 Feb 14;13:782199. doi: 10.3389/fphar.2022.782199. eCollection 2022.
6
Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System.尿毒症毒素:关乎心血管系统的一种惊人危险。
Front Physiol. 2021 May 14;12:686249. doi: 10.3389/fphys.2021.686249. eCollection 2021.
7
Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study.血液透析患者的血清总硫酸吲哚酚与临床结局:日本透析结局与实践模式研究结果
Clin Kidney J. 2020 Jul 31;14(4):1236-1243. doi: 10.1093/ckj/sfaa121. eCollection 2021 Apr.
8
Uremia Coupled with Mucosal Damage Predisposes Mice with Kidney Disease to Systemic Infection by Commensal .尿毒症合并黏膜损伤使肾病小鼠易发生共生菌的全身感染。
Immunohorizons. 2021 Jan 15;5(1):16-24. doi: 10.4049/immunohorizons.2000114.
9
Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease.恢复葡萄糖摄取可挽救中性粒细胞功能障碍,并在肾病小鼠模型中预防全身性真菌感染。
Sci Transl Med. 2020 Jun 17;12(548). doi: 10.1126/scitranslmed.aay5691.
10
Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).二乙烯基苯树脂去除血液透析患者中吲哚硫酸酯和对甲酚硫酸酯的疗效:一项体外研究和一项体内初步试验的结果 (xuanro4-Nature 3.2)。
Toxins (Basel). 2020 Mar 10;12(3):170. doi: 10.3390/toxins12030170.

本文引用的文献

1
Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.用液相色谱/串联质谱法测定血液透析患者的蛋白结合型尿毒症毒素及其对内皮细胞 ROS 产生的影响。
Anal Bioanal Chem. 2012 Jun;403(7):1841-50. doi: 10.1007/s00216-012-5929-3. Epub 2012 Mar 25.
2
Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications.同时测定对甲酚硫酸盐和对甲酚葡萄糖醛酸苷的新方法:临床数据及病理生理学意义
Nephrol Dial Transplant. 2012 Jun;27(6):2388-96. doi: 10.1093/ndt/gfr672. Epub 2011 Dec 13.
3
Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.在夜间间歇性血液透析中,以蛋白结合溶质的减少作为透析效果的标志物是不可接受的。
Am J Nephrol. 2011;34(3):226-32. doi: 10.1159/000330176. Epub 2011 Jul 23.
4
Colonic contribution to uremic solutes.肠道对尿毒症溶质的贡献。
J Am Soc Nephrol. 2011 Sep;22(9):1769-76. doi: 10.1681/ASN.2010121220. Epub 2011 Jul 22.
5
Update of uremic toxin research by mass spectrometry.采用质谱技术对尿毒症毒素的研究进展更新。
Mass Spectrom Rev. 2011 May-Jun;30(3):510-21. doi: 10.1002/mas.20323. Epub 2011 Feb 16.
6
Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.应用液相色谱/串联质谱法对口服吸附剂 AST-120 的作用进行代谢组学搜索,以寻找尿毒症毒素作为其作用的指标。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 1;878(29):2997-3002. doi: 10.1016/j.jchromb.2010.09.006. Epub 2010 Sep 15.
7
Indoxyl sulfate is a nephro-vascular toxin.硫酸吲哚酚是一种肾血管毒素。
J Ren Nutr. 2010 Sep;20(5 Suppl):S2-6. doi: 10.1053/j.jrn.2010.05.002.
8
Uremic toxicity of indoxyl sulfate.硫酸吲哚酚的尿毒症毒性。
Nagoya J Med Sci. 2010 Feb;72(1-2):1-11.
9
The gut: the forgotten organ in uremia?肠道:尿毒症中被遗忘的器官?
Blood Purif. 2010;29(2):130-6. doi: 10.1159/000245639. Epub 2010 Jan 8.
10
Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry.采用液相色谱/电喷雾电离-串联质谱法对尿毒症毒素进行代谢组学分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jun 15;878(20):1662-8. doi: 10.1016/j.jchromb.2009.11.040. Epub 2009 Dec 3.

采用液相色谱-串联质谱法测定血液透析患者血清中蛋白结合尿毒症毒素水平的相关性

Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.

作者信息

Itoh Yoshiharu, Ezawa Atsuko, Kikuchi Kaori, Tsuruta Yoshinari, Niwa Toshimitsu

机构信息

Biomedical Research Laboratories, Kureha Corporation.

Meiyo Clinic.

出版信息

Mass Spectrom (Tokyo). 2013;2(Spec Iss):S0017. doi: 10.5702/massspectrometry.S0017. Epub 2013 Apr 15.

DOI:10.5702/massspectrometry.S0017
PMID:24349936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3810223/
Abstract

Uremic toxins are involved in a variety of symptoms in advanced chronic kidney disease. Especially, the accumulation of protein-bound uremic toxins in the blood of dialysis patients might play an important role in the development of cardiovascular disease. Serum concentration of protein-bound uremic toxins such as indoxyl sulfate, indoxyl glucuronide, indoleacetic acid, p-cresyl sulfate, p-cresyl glucuronide, phenyl sulfate, phenyl glucuronide, phenylacetic acid, phenylacetylglutamine, hippuric acid, 4-ethylphenyl sulfate, and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF) in hemodialysis patients were simultaneously measured by liquid chromatography/tandem mass spectrometry. Serum levels of these protein-bound uremic toxins were increased in hemodialysis patients. Indoxyl sulfate, p-cresyl sulfate, and CMPF could not be removed efficiently by hemodialysis due to their high protein-binding ratios. Serum level of total indoxyl sulfate did not show any significant correlation with total p-cresyl sulfate. However, free indoxyl sulfate correlated with free p-cresyl sulfate, and reduction rate by hemodialysis of indoxyl sulfate correlated with that of p-cresyl sulfate. Serum levels of total and free indoxyl sulfate showed significantly positive correlation with those of indoxyl glucuronide, phenyl sulfate, and phenyl glucuronide. Serum levels of total and free p-cresyl sulfate showed significantly positive correlation with those of p-cresyl glucuronide, phenylacetylglutamine, and phenylacetic acid. Indoxyl sulfate and indoxyl glucuronide are produced from indole which is produced in the intestine from tryptophan by intestinal bacteria. p-Cresyl sulfate and p-cresyl glucuronide are produced from p-cresol which is produced in the intestine from tyrosine by intestinal bacteria. Thus, intestinal bacteria play an important role in the metabolism of protein-bound uremic toxins.

摘要

尿毒症毒素与晚期慢性肾脏病的多种症状有关。特别是,透析患者血液中蛋白结合型尿毒症毒素的蓄积可能在心血管疾病的发生发展中起重要作用。采用液相色谱/串联质谱法同时测定血液透析患者血清中硫酸吲哚酚、吲哚酚葡萄糖醛酸苷、吲哚乙酸、对甲酚硫酸盐、对甲酚葡萄糖醛酸苷、苯硫酸盐、苯葡萄糖醛酸苷、苯乙酸、苯乙酰谷氨酰胺、马尿酸、4-乙基苯硫酸盐和3-羧基-4-甲基-5-丙基-2-呋喃丙酸(CMPF)等蛋白结合型尿毒症毒素的浓度。血液透析患者这些蛋白结合型尿毒症毒素的血清水平升高。由于硫酸吲哚酚、对甲酚硫酸盐和CMPF的蛋白结合率高,血液透析不能有效清除它们。总硫酸吲哚酚的血清水平与总对甲酚硫酸盐无显著相关性。然而,游离硫酸吲哚酚与游离对甲酚硫酸盐相关,硫酸吲哚酚的血液透析清除率与对甲酚硫酸盐的清除率相关。总硫酸吲哚酚和游离硫酸吲哚酚的血清水平与吲哚酚葡萄糖醛酸苷、苯硫酸盐和苯葡萄糖醛酸苷的血清水平呈显著正相关。总对甲酚硫酸盐和游离对甲酚硫酸盐的血清水平与对甲酚葡萄糖醛酸苷、苯乙酰谷氨酰胺和苯乙酸的血清水平呈显著正相关。硫酸吲哚酚和吲哚酚葡萄糖醛酸苷由吲哚产生,吲哚是肠道细菌在肠道内由色氨酸产生的。对甲酚硫酸盐和对甲酚葡萄糖醛酸苷由对甲酚产生,对甲酚是肠道细菌在肠道内由酪氨酸产生的。因此,肠道细菌在蛋白结合型尿毒症毒素的代谢中起重要作用。